Will This Price Target Increase Help Cardinal Health (CAH) Stock Today?

NEW YORK (TheStreet) -- UBS increased its price target on Cardinal Health  (CAH) to $80 from $77 and set a "buy" rating. The firm noted a positive outlook on the fourth-quarter of the fiscal year 2014 after peers reported strong results.

The stock closed at $72.37 on Friday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

-----------

Separately, TheStreet Ratings team rates CARDINAL HEALTH INC as a "buy" with a ratings score of B+. TheStreet Ratings Team has this to say about their recommendation:

"We rate CARDINAL HEALTH INC (CAH) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income."

You can view the full analysis from the report here: CAH Ratings Report

CAH Chart CAH data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

These Stocks Pay You to Own Them

FDA Official Calls for Ending Codeine Use in Kids Cough Products

Big Drug Makers Could Face More Pressure on Codeine Remedies for Kids

Cramer: Finding the Flaws in Amazon

Cardinal Health: Cramer's Top Takeaways